Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis.

Francesco Paolo Bianchi, Pasquale Stefanizzi, Antonio Di Lorenzo, Chiara De Waure, Stefania Boccia, Antonio Daleno, Giovanni Migliore, Silvio Tafuri
Author Information
  1. Francesco Paolo Bianchi: Department of Interdisciplinary Medicine, Aldo Moro University of Bari, Bari, Italy. ORCID
  2. Pasquale Stefanizzi: Department of Interdisciplinary Medicine, Aldo Moro University of Bari, Bari, Italy.
  3. Antonio Di Lorenzo: Department of Interdisciplinary Medicine, Aldo Moro University of Bari, Bari, Italy.
  4. Chiara De Waure: Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
  5. Stefania Boccia: Section of Hygiene, University Department of Life Sciences and Public Health, University Cattolica of Sacred Hearth, Rome, Italy.
  6. Antonio Daleno: Health Direction, University-General Hospital Policlinico, Bari, Italy.
  7. Giovanni Migliore: Health Direction, University-General Hospital Policlinico, Bari, Italy.
  8. Silvio Tafuri: Department of Interdisciplinary Medicine, Aldo Moro University of Bari, Bari, Italy. ORCID

Abstract

Healthcare workers (HCWs) are among the at-risk groups for whom influenza vaccination is strongly recommended. To assess the proportion of Italian HCWs with positive attitudes toward influenza vaccination, we conducted a systematic review of relevant literature and a meta-analysis. Our focus was on the influenza seasons from 2017/18 to 2021/22. The prevalence of favorable attitudes toward vaccination varied, ranging from 12% during the 2017/18 influenza season to 59% in the 2020/21 season. The significant increase in the 2020/21 season can be attributed to adaptations necessitated by the COVID-19 pandemic. During the 2021/22 influenza season, there was a decline in vaccination coverage (37%), likely due to the absence of a robust preventive culture. Various strategies have been employed to enhance HCWs' attitudes to achieve higher vaccination rates, but none of them have demonstrated satisfactory results. Policymakers should consider implementing a policy of mandatory vaccination to ensure elevated vaccination coverage among HCWs.

Keywords

References

  1. Am J Infect Control. 2020 Apr;48(4):368-374 [PMID: 31753548]
  2. Expert Rev Vaccines. 2010 Mar;9(3):277-83 [PMID: 20218856]
  3. Vaccines (Basel). 2021 Jul 09;9(7): [PMID: 34358182]
  4. BMJ. 2021 Mar 29;372:n71 [PMID: 33782057]
  5. Int J Environ Res Public Health. 2020 Oct 01;17(19): [PMID: 33019559]
  6. Vaccines (Basel). 2021 Jun 24;9(7): [PMID: 34202867]
  7. Vaccines (Basel). 2022 Mar 18;10(3): [PMID: 35335106]
  8. Can J Infect Dis. 2000 Sep;11(5):225-6 [PMID: 18159292]
  9. Ann Ig. 2022 Nov-Dec;34(6):650-655 [PMID: 35107123]
  10. Hum Vaccin Immunother. 2022 Dec 31;18(1):1978795 [PMID: 34613881]
  11. Vaccines (Basel). 2021 Jun 10;9(6): [PMID: 34200835]
  12. Eur J Public Health. 2022 Apr 1;32(2):207-213 [PMID: 35021201]
  13. J Prev Med Hyg. 2022 Oct 27;63(3):E405-E414 [PMID: 36415296]
  14. Hum Vaccin Immunother. 2015;11(1):133-9 [PMID: 25483526]
  15. Int J Environ Res Public Health. 2020 May 03;17(9): [PMID: 32375260]
  16. Hum Vaccin. 2011 Jul;7(7):728-33 [PMID: 21705859]
  17. Hum Vaccin Immunother. 2021 Dec 2;17(12):5388-5389 [PMID: 34847813]
  18. BMC Health Serv Res. 2020 Aug 18;20(1):763 [PMID: 32811477]
  19. Hum Vaccin Immunother. 2020;16(1):81-85 [PMID: 31210582]
  20. Int J Environ Res Public Health. 2021 Dec 11;18(24): [PMID: 34948694]
  21. Vaccines (Basel). 2021 Mar 18;9(3): [PMID: 33803755]
  22. Vaccines (Basel). 2022 Oct 29;10(11): [PMID: 36366344]
  23. Vaccines (Basel). 2022 Aug 18;10(8): [PMID: 36016229]
  24. Vaccines (Basel). 2022 May 31;10(6): [PMID: 35746492]
  25. Saf Health Work. 2022 Mar;13(1):59-65 [PMID: 35936207]
  26. Expert Rev Vaccines. 2023 Jan-Dec;22(1):17-24 [PMID: 36409195]
  27. Vaccines (Basel). 2020 Feb 13;8(1): [PMID: 32069869]
  28. Vaccines (Basel). 2019 Nov 29;7(4): [PMID: 31795438]
  29. Vaccines (Basel). 2021 Aug 30;9(9): [PMID: 34579208]
  30. Vaccines (Basel). 2022 Oct 25;10(11): [PMID: 36366302]
  31. Int J Environ Res Public Health. 2022 Jan 10;19(2): [PMID: 35055555]
  32. Int J Environ Res Public Health. 2018 Apr 24;15(5): [PMID: 29695117]
  33. Occup Med (Lond). 2020 Dec 30;70(9):665-671 [PMID: 33300998]
  34. Vaccines (Basel). 2022 Sep 07;10(9): [PMID: 36146570]
  35. Int J Environ Res Public Health. 2019 Jun 05;16(11): [PMID: 31195661]
  36. Vaccines (Basel). 2022 Jun 19;10(6): [PMID: 35746583]
  37. Eur J Public Health. 2021 Feb 1;31(1):56 [PMID: 33001212]
  38. Vaccines (Basel). 2020 Jul 11;8(3): [PMID: 32664507]
  39. Int J Environ Res Public Health. 2020 May 30;17(11): [PMID: 32486224]
  40. Acta Biomed. 2021 Oct 19;92(S6):e2021447 [PMID: 34739469]
  41. Healthcare (Basel). 2020 Dec 23;9(1): [PMID: 33374510]
  42. Ital J Pediatr. 2019 Apr 11;45(1):47 [PMID: 30975224]
  43. Int J Environ Res Public Health. 2022 May 26;19(11): [PMID: 35682083]
  44. J Infect Dis. 2021 Aug 2;224(3):431-434 [PMID: 34007998]
  45. Vaccines (Basel). 2020 Nov 16;8(4): [PMID: 33207626]
  46. BMJ. 2015 Jan 14;350:h116 [PMID: 25589037]
  47. Vaccines (Basel). 2021 Jul 09;9(7): [PMID: 34358185]
  48. J Am Dent Assoc. 2021 Sep;152(9):740-746 [PMID: 34301398]
  49. Ann Ig. 2022 Jun 15;34(4):344-357 [PMID: 34821928]
  50. MMWR Morb Mortal Wkly Rep. 2018 Sep 28;67(38):1050-1054 [PMID: 30260944]
  51. Viruses. 2021 Feb 26;13(3): [PMID: 33652829]
  52. J Prev Med Hyg. 2021 Jan 14;61(4):E563-E567 [PMID: 33628962]
  53. Vaccines (Basel). 2020 May 24;8(2): [PMID: 32456273]
  54. Vaccines (Basel). 2020 Mar 26;8(2): [PMID: 32225018]
  55. Hum Vaccin Immunother. 2019;15(12):2927-2932 [PMID: 31157586]
  56. J Eval Clin Pract. 2020 Aug;26(4):1205-1211 [PMID: 31697012]
  57. Hum Vaccin Immunother. 2022 Nov 30;18(6):2116206 [PMID: 36197125]
  58. Int J Environ Res Public Health. 2020 Mar 12;17(6): [PMID: 32178426]
  59. Hum Vaccin Immunother. 2022 Dec 31;18(1):1993039 [PMID: 34736372]

MeSH Term

Humans
Influenza, Human
Pandemics
Attitude of Health Personnel
COVID-19
Vaccination
Health Personnel
Italy
Influenza Vaccines
Surveys and Questionnaires

Chemicals

Influenza Vaccines

Word Cloud

Created with Highcharts 10.0.0vaccinationinfluenzaseasonworkersHCWsattitudestowardHealthcareamongsystematicreviewmeta-analysis2017/182021/222020/21COVID-19coverageat-riskgroupsstronglyrecommendedassessproportionItalianpositiveconductedrelevantliteraturefocusseasonsprevalencefavorablevariedranging12%59%significantincreasecanattributedadaptationsnecessitatedpandemicdecline37%likelydueabsencerobustpreventivecultureVariousstrategiesemployedenhanceHCWs'achievehigherratesnonedemonstratedsatisfactoryresultsPolicymakersconsiderimplementingpolicymandatoryensureelevatedAttitudeshealthcareItaly:managementsusceptiblenosocomialinfectionpublichealth

Similar Articles

Cited By